Profile data is unavailable for this security.
About the company
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
- Revenue in USD (TTM)1.72m
- Net income in USD-22.86m
- Incorporated1997
- Employees36.00
- LocationSol Gel Technologies LtdGolda Meir 7NESS-ZIONA 7403650IsraelISR
- Phone+972 89313433
- Fax+972 89313434
- Websitehttp://www.sol-gel.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics Inc | 0.00 | -14.98m | 20.24m | 7.00 | -- | 2.16 | -- | -- | -1.78 | -1.78 | 0.00 | 1.10 | 0.00 | -- | -- | 0.00 | -87.86 | -66.55 | -97.46 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
| Bioxytran Inc | 0.00 | -4.30m | 20.47m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| Ibio Inc | 50.00k | -17.13m | 20.52m | 26.00 | -- | 0.8153 | -- | 410.49 | -13.10 | -17.09 | 0.0262 | 2.92 | 0.0011 | -- | 0.0065 | 1,923.08 | -36.24 | -28.09 | -67.39 | -32.63 | -- | -- | -34,258.00 | -1,467.30 | -- | -- | 0.3666 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
| Jaguar Health Inc | 10.14m | -38.32m | 20.63m | 49.00 | -- | 1.60 | -- | 2.03 | -78.63 | -78.63 | 9.90 | 3.18 | 0.1806 | 0.2397 | 8.12 | 206,938.80 | -69.22 | -95.29 | -122.86 | -163.54 | 79.07 | 67.28 | -383.35 | -522.28 | 1.39 | -2.78 | 0.6919 | -- | -18.36 | 17.19 | 12.97 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 38.83m | -8.42m | 21.00m | 91.00 | -- | 0.7624 | -- | 0.541 | -0.596 | -0.596 | 2.72 | 1.94 | 0.4542 | 0.8812 | 3.08 | 426,654.70 | -9.83 | -7.03 | -14.07 | -9.52 | 83.54 | 79.95 | -21.65 | -17.64 | 1.21 | -37.10 | 0.3717 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Polypid Ltd | 0.00 | -24.25m | 21.59m | 59.00 | -- | 3.02 | -- | -- | -12.35 | -12.35 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -84.94 | -76.92 | -120.03 | -89.61 | -- | -- | -- | -- | -- | -28.72 | 0.5498 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
| Forte Biosciences Inc | 0.00 | -32.14m | 21.64m | 11.00 | -- | 0.7534 | -- | -- | -1.03 | -1.03 | 0.00 | 0.7882 | 0.00 | -- | -- | 0.00 | -93.54 | -72.06 | -104.30 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
| Sol Gel Technologies Ltd | 1.72m | -22.86m | 22.29m | 36.00 | -- | 0.6826 | -- | 12.96 | -0.8222 | -0.8222 | 0.0619 | 1.17 | 0.0387 | -- | 0.5154 | 47,777.78 | -51.40 | -31.60 | -57.29 | -35.49 | -- | -- | -1,329.13 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 22.54m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Zivo Bioscience Inc | 63.37k | -7.08m | 22.54m | 8.00 | -- | -- | -- | 355.72 | -3.83 | -3.83 | 0.0318 | -0.8133 | 0.0652 | -- | -- | 7,921.25 | -728.52 | -376.60 | -- | -- | 38.05 | -- | -11,176.47 | -96,315.32 | -- | -88.46 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
| Bullfrog AI Holdings, Inc. | 65.00k | -5.95m | 22.69m | 4.00 | -- | 3.33 | -- | 349.05 | -0.8903 | -0.8903 | 0.0097 | 0.8667 | 0.0094 | -- | -- | 16,250.00 | -85.49 | -- | -103.85 | -- | 92.00 | -- | -9,129.42 | -- | -- | -278.20 | 0.0694 | -- | 550.00 | -- | -91.11 | -- | -- | -- |
| Cocrystal Pharma Inc | 0.00 | -16.75m | 22.89m | 12.00 | -- | 1.01 | -- | -- | -1.65 | -1.65 | 0.00 | 2.22 | 0.00 | -- | -- | 0.00 | -52.03 | -50.94 | -56.92 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
| Biora Therapeutics Inc | 544.00k | -111.08m | 22.96m | 58.00 | -- | -- | -- | 42.20 | -7.13 | -7.12 | 0.0267 | -3.29 | 0.0143 | -- | 0.6594 | 9,379.31 | -291.43 | -122.84 | -482,965.20 | -369.01 | -- | -- | -20,419.48 | -415.10 | -- | -- | -- | -- | -98.69 | -87.44 | -154.63 | -- | -53.68 | -- |
| Nymox Pharmaceutical Corp | 0.00 | -4.87m | 24.25m | 3.00 | -- | -- | -- | -- | -0.0536 | -0.0536 | 0.00 | -0.0204 | 0.00 | -- | -- | -- | -255.75 | -264.40 | -- | -464.48 | -- | -- | -- | -13,001.67 | -- | -42.44 | -- | -- | -- | -- | 47.55 | -- | -- | -- |
| SAB Biotherapeutics Inc | 2.60m | -39.87m | 24.37m | 57.00 | -- | 0.4613 | -- | 9.36 | -6.26 | -6.26 | 0.396 | 5.72 | 0.0456 | -- | 5.44 | 45,657.37 | -69.91 | -- | -86.60 | -- | -- | -- | -1,531.84 | -- | -- | -- | 0.0762 | -- | -90.63 | -- | -125.14 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Sol Gel Technologies Ltd's reporting currency: US Dollar USD
27.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Phoenix Investments House Ltd.as of 31 Mar 2024 | 2.57m | 9.24% |
| Armistice Capital LLCas of 31 Mar 2024 | 2.08m | 7.46% |
| Migdal Insurance Co. Ltd. (Investment Portfolio)as of 31 Mar 2024 | 1.23m | 4.41% |
| Harel Mutual Funds Ltd.as of 31 Mar 2024 | 920.33k | 3.30% |
| Kingdon Capital Management LLCas of 31 Mar 2024 | 481.75k | 1.73% |
| Yelin Lapidot Mutual Fund Management Ltd.as of 31 Mar 2024 | 229.18k | 0.82% |
| Raymond James Financial Services Advisors, Inc.as of 31 Mar 2024 | 49.13k | 0.18% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 33.71k | 0.12% |
| Raymond James & Associates, Inc. (Invt Mgmt)as of 31 Mar 2024 | 30.98k | 0.11% |
| Millennium Management LLCas of 31 Mar 2024 | 20.40k | 0.07% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
